发明名称 |
Antibodies comprising chimeric constant domains |
摘要 |
Antibodies, antigen-binding proteins and Fc-fusion proteins that comprise recombinant polypeptides containing a chimeric heavy chain constant region sequence are provided that bind to certain Fc receptors however have reduced effector functions. Methods of making constructs for expression of such chimeric Fc-containing antibodies, antigen-binding proteins and Fc-fusion proteins in cell systems, and methods of producing and isolating the chimeric Fc-containing proteins are provided. |
申请公布号 |
US9359437(B2) |
申请公布日期 |
2016.06.07 |
申请号 |
US201414170166 |
申请日期 |
2014.01.31 |
申请人 |
Regeneron Pharmaceuticals, Inc. |
发明人 |
Davis Samuel;Smith Eric;Patel Supriya |
分类号 |
C12P21/08;C07K16/28;C07K16/46 |
主分类号 |
C12P21/08 |
代理机构 |
Alston & Bird LLP |
代理人 |
Alston & Bird LLP ;Johnson Mary C. |
主权项 |
1. A recombinant polypeptide comprising a heavy chain constant (CH) region comprising, from N-terminus to C-terminus, a CH1 domain, a chimeric hinge, a CH2 domain, and a CH3 domain wherein:
(a) the CH1 domain comprises the amino acid sequence DKKV or DKRV from positions 212 to 215 (EU numbering), (b) the chimeric hinge comprises a human IgG1 or a human IgG4 upper hinge amino acid sequence from positions 216 to 227 (EU numbering) and a human IgG2 lower hinge amino acid sequence PCPAPPVA (SEQ ID NO: 3) from positions 228 to 236 (EU numbering), (c) the CH2 domain comprises a human IgG4 CH2 domain amino acid sequence from positions 237 to 340 (EU numbering) comprising the amino acid sequence of SEQ ID NO: 10, and (d) the CH3 domain comprises a human IgG1 or a human IgG4 CH3 domain sequence from positions 341 to 447 (EU numbering). |
地址 |
Tarrytown NY US |